Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „under“
Suchtreffer
Begriffe & Kennungen
2nd-5th toe middle phalangeal hypoplasia
Eintrag öffnenAbasaglar (previously Abasria) · 4.5 · In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guaneth
Eintrag öffnenAbasaglar (previously Abasria) · 4.5 · In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guaneth
Eintrag öffnenAbevmy · 4.8 · Bevacizumab is not approved for use in patients under the age of 18 years. In published literature reports, ca
Eintrag öffnenAbflachung der Ohrmuschel
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbsent/hypoplastic coccyx
Eintrag öffnenAccofil · 4.8 · 32 d Cases were observed in the post-marketing setting in patients undergoing bone marrow transplant or PBPC m
Eintrag öffnenAchselhöhle
Eintrag öffnenActelsar HCT · 4.8 · Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥1
Eintrag öffnenActelsar HCT · 4.8 · Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥1
Eintrag öffnenAdempas · 4.8 · The most commonly reported adverse reactions, occurring in ≥ 10% of patients under riociguat treatment (up to
Eintrag öffnenAdempas · 4.8 · The most commonly reported adverse reactions, occurring in ≥ 10% of patients under riociguat treatment (up to
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.5 · 4 The immunological response may be diminished if the patient is undergoing immunosuppressant treatment.
Eintrag öffnenAdrenal hypoplasia
Eintrag öffnenAdtralza · 4.5 · Tralokinumab is not expected to undergo metabolism by hepatic enzymes or renal elimination. Clinically relevan
Eintrag öffnenAerinaze · 4.8 · 7 Other adverse reactions reported for desloratadine during the post-marketing period are listed hereunder.
Eintrag öffnenAgave
Eintrag öffnenAldurazyme · 4.8 · Paediatric population ADRs to Aldurazyme reported during a Phase 2 study in a total of 20 patients, under 5 ye
Eintrag öffnen